Choosing the right device to regulate or jump-start the heart can be a challenge. Not only does a patient’s symptoms often dictate whether a pacemaker or defibrillator is a more appropriate treatment, but new advances in technology are making the choice between available devices more difficult.

The recent revelation that MRSA is killing more Americans than AIDs compels us to look for better answers, and fast. A simple one which could have a huge impact involves how we communicate the location of isolated MRSA patients to house keepers, transport personnel and other staff.

March 11, 2008 - St. Jude Medical Inc. received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW), in addition to reimbursement approval, of the SJM Tailor Flexible Ring and SJM Tailor Flexible Band, allowing the company to offer its first valve repair solution in Japan.

The Tailor Flexible Ring and the C-shaped Tailor Flexible Band are designed to provide surgeons with a range of easy-to-implant options for the repair of the heart’s mitral and tricuspid valves.

March 11, 2008 - Diets rich magnesium, found in whole grains and vegetables, could help reduce stroke risk in smokers, researchers Susanna Larsson and colleagues at the Karolinska Institute in Stockholm, Sweden, reported.

Their study of 26,000 male smokers in Finland found that those whose diets were high in magnesium had a significantly lower risk of one type of stroke.

March 11, 2008 - Cardiac Science Corp. completed a delivery of 282 electrocardiograph systems (ECGs) to Mexico’s Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), representing the single largest ECG order in Cardiac Science history.

March 11, 2008 – Medtronic Inc. will feature its newly FDA-cleared Endeavor Zotarolimus-Eluting Coronary Stent System (Endeavor) at the American College of Cardiology's 57th Annual Scientific Session, from March 29-April 1, in Chicago, IL, marking a major development in the field of interventional cardiology for the company.

Endeavor is engineered for the treatment of coronary artery disease. The stent’s design combines a stent platform with the drug zotarolimus and a biocompatible polymer.

March 11, 2008 - Sorin Group's ELA Medical received the FDA’s approval to market ISOLINE, a new defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety, in a move that strengthens the company’s position in the U.S. market.

March 11, 2008 - Abbott announced today that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm version of its XIENCE V Everolimus Eluting Coronary Stent System, offering physicians a smaller stent based upon the safety results and deliverability of XIENCE V.

March 10, 2008 – On March 10 and 11, at Rush University Medical Center (RUSH), Chicago, IL, a mechanical circulatory support and heart transplant team will participate in the first phase of certification training for the CardioWest temporary Total Artificial Heart (TAH-t), which could designate Rush as one of the first U.S. healthcare facilities able to discharge artificial heart patients home for their recovery.

March 11, 2008 – Bayer HealthCare Pharmaceuticals Inc. unveiled plans to launch VistaTrak, a contrast media management system that provides a new management tool designed to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now